arrow
K

Kai Markus Schneider

University of Pennsylvania
H指数:29
被引数:3,550

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Distinct Plasma Proteomic Signatures Distinguish MASLD From Non-Steatotic Individuals but Not From MetALD

不同血浆蛋白质组学特征可区分MASLD与非脂肪变性个体,但无法区分MASLD与MetALD

2026-09-300
OAAI
Alpha-1 Antitrypsin Deficiency Alleles in Non-Cirrhotic Hepatocellular Carcinoma: Insights from a Multicenter French Cohort

α-1抗胰蛋白酶缺乏等位基因在非肝硬化肝癌中的研究:来自法国多中心队列的见解

2026-04-030
OAAI
C-reactive protein and cardiovascular risk in the general population

C-反应蛋白和普通人群中的心血管风险

2025-12-011
PRE
Characterization of a novel SERPINA1 variant carrying two missense mutations: molecular mechanisms and functional impact

一种携带两个错义突变的SERPINA1新变异体的表征:分子机制与功能影响

2025-11-220
OA
Fiber enrichment is not superior to dietary monitoring in MASLD: A dual-center, double-blind, placebo-controlled trial

纤维补充不优于饮食监测在MASLD中:一项双中心、双盲、安慰剂对照试验

2025-11-110
OAAI
The Impact of Access to Clinical Guidelines on LLM-Based Treatment Recommendations for Chronic Hepatitis B

临床指南获取对LLM基于慢性乙型肝炎治疗建议的影响

2025-09-020
OAAI
Shear stress-induced endothelial HEG1 signalling regulates vascular tone and blood pressure

剪切应力诱导的内皮HEG1信号通路调控血管张力和血压

2025-09-011
PRE
Differential protective roles of c-Jun N-terminal kinase-2 in non-parenchymal liver cells and hepatocytes during cholestasis

胆汁淤积期间c-Jun N末端激酶-2在非实质肝细胞和肝细胞中的差异性保护作用

2025-07-160
OAAI
Insulin-like Growth Factor-1 Reflects Liver Disease Stage and Improves Prediction of Liver-related Mortality

胰岛素样生长因子-1反映肝脏疾病分期并改善肝相关死亡预测

2025-05-140
OAAI
Mutational Analysis of Bile Cell-Free DNA in Primary Sclerosing Cholangitis: A Pilot Study

原发性硬化性胆管炎中胆汁游离DNA的突变分析: 一项初步研究

2025-04-010
OAAI